Gerard Cote

Dr. Coté is a world-wide expert in biomedical sensing for diagnostic and monitoring applications. Specifically, he develops hand-held and wearable point-of-care technologies and systems using optics, electronics, microfluidics, paper fluidics, nanoparticles, and assays. Applications include detection and diagnosis of chronic diseases (diabetes, cardiovascular, cancer), blood toxins (BPA, PCBs), and infectious disease (malaria) with a recent focus on underserved populations. He has coauthored over 300 publications, proceedings, and abstracts, leading to him being named Fellow of four societies including the Institute of Electrical and Electronics Engineers (IEEE), the American Institute for Medical and Biological Engineering (AIMBE), the Biomedical Engineering Society (BMES), and the international Society for Optics and Photonics (SPIE). His research is multidisciplinary and involves several investigators from across the world including medical doctors, life science faculty, faculty from other engineering disciplines, national laboratory staff and industry personnel. Dr. Coté also performs translational research and contributes to the innovation ecosystem. He holds several U.S. patents, works with large and small companies, and co-founded four medical device companies namely; DexNeo, BioTex, BasePair BioTechnologies, and Visualase (acquired by Medtronic).

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]